AIRLINK 74.00 Decreased By ▼ -0.25 (-0.34%)
BOP 5.14 Increased By ▲ 0.09 (1.78%)
CNERGY 4.55 Increased By ▲ 0.13 (2.94%)
DFML 37.15 Increased By ▲ 1.31 (3.66%)
DGKC 89.90 Increased By ▲ 1.90 (2.16%)
FCCL 22.40 Increased By ▲ 0.20 (0.9%)
FFBL 33.03 Increased By ▲ 0.31 (0.95%)
FFL 9.75 Decreased By ▼ -0.04 (-0.41%)
GGL 10.75 Decreased By ▼ -0.05 (-0.46%)
HBL 115.50 Decreased By ▼ -0.40 (-0.35%)
HUBC 137.10 Increased By ▲ 1.26 (0.93%)
HUMNL 9.95 Increased By ▲ 0.11 (1.12%)
KEL 4.60 Decreased By ▼ -0.01 (-0.22%)
KOSM 4.83 Increased By ▲ 0.17 (3.65%)
MLCF 39.75 Decreased By ▼ -0.13 (-0.33%)
OGDC 138.20 Increased By ▲ 0.30 (0.22%)
PAEL 27.00 Increased By ▲ 0.57 (2.16%)
PIAA 24.24 Decreased By ▼ -2.04 (-7.76%)
PIBTL 6.74 Decreased By ▼ -0.02 (-0.3%)
PPL 123.62 Increased By ▲ 0.72 (0.59%)
PRL 27.40 Increased By ▲ 0.71 (2.66%)
PTC 13.90 Decreased By ▼ -0.10 (-0.71%)
SEARL 61.75 Increased By ▲ 3.05 (5.2%)
SNGP 70.15 Decreased By ▼ -0.25 (-0.36%)
SSGC 10.52 Increased By ▲ 0.16 (1.54%)
TELE 8.57 Increased By ▲ 0.01 (0.12%)
TPLP 11.10 Decreased By ▼ -0.28 (-2.46%)
TRG 64.02 Decreased By ▼ -0.21 (-0.33%)
UNITY 26.76 Increased By ▲ 0.71 (2.73%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 7,874 Increased By 36.2 (0.46%)
BR30 25,596 Increased By 136 (0.53%)
KSE100 75,342 Increased By 411.7 (0.55%)
KSE30 24,214 Increased By 68.6 (0.28%)

FRANKFURT: The European Union-wide rollout of Pfizer and BioNTech's COVID-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week earlier than previously planned, Germany's health ministry said on Wednesday.

"Given the current pandemic situation, this is good news for parents and children. Many are awaiting this eagerly," acting health minister Jens Spahn said in the statement.

Germany is due to receive 2.4 million doses for use as a two-dose regimen, the ministry said, adding it has commitment on the new date from the manufacturer.

Germany's regional health ministers on Monday agreed to prepare for the launch, with offerings such as family sections within vaccination centres.

A BioNTech spokesperson confirmed the earlier start, adding it was contingent on the production batch passing quality control checks early next week.

The rollout will be brought forward without an impact on agreed delivery volumes thanks to "a massive effort including weekend work" on the part of Pfizer and BioNTech staff, the company added.

It said that while BioNTech had been in discussions with the EU Commission about the pandemic situation, it had not received a direct request for faster delivery. An EU official confirmed that the Commission had not prompted the move.

Germany reports highest daily COVID-19 death toll for 9 months

The EU last week approved use of the low-dose vaccine version for five- to 11-year-olds, following authorisation in May to give the standard adult dosage to children 12 years and older.

Pent-up demand for a shot for the youngest has been palpable in some countries. In hard-hit Austria, where the government has reimposed a nationwide lockdown, some provinces have been vaccinating five to 11-year-old children with a lower dose of the adult vaccine even before the EU recommendation.

Denmark followed suit with that method on Sunday, saying there was no time to lose amid rising infections among the youngest.

Coronavirus is spreading faster in Europe than in other world regions, prompting a scramble to persuade non-vaccinated adults to get shots, to get a campaign for third booster doses off the ground and to inoculate children.

Uncertainty over Omicron, the highly contagious new variant first detected in South Africa, has added urgency to the fight against the pandemic on many fronts.

Recorded infections among school-age children in Germany have surged and have been about twice as high as the all-age average over the last few weeks.

Frequent testing in classrooms may be bringing more asymptomatic cases to light than in the overall population.

The United States started distributing the paediatric version of the Pfizer shot in early November, followed by Canada in mid-November.

Comments

Comments are closed.